RxSight, Inc. Announces Pricing of Initial Public Offering by Carolyn Helms | Jul 30, 2021 | Portfolio News
Cohere Health Announces a Groundbreaking Collaboration with American College of Cardiology to Advance High-Quality Care by Carolyn Helms | Jul 28, 2021 | Portfolio News
Poseida Therapeutics Appoints Cynthia Collins to Board of Directors by Carolyn Helms | Jul 26, 2021 | Portfolio News
LEXEO Therapeutics Expands Cardiac Gene Therapy Pipeline with Acquisition of Stelios Therapeutics and its Gene Therapy Programs for Rare Cardiovascular Diseases by Carolyn Helms | Jul 21, 2021 | Portfolio News
Inozyme Pharma Receives Orphan Drug Designation for INZ-701 from the European Medicines Agency for the Treatment of ABCC6 Deficiency by Carolyn Helms | Jul 21, 2021 | Portfolio News
